Published on : Aug 11, 2016
ALBANY, New York, August 11, 2016: ResearchMoz.us has announced the addition of a new report, titled “Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape,” to its offering. A number of industry experts and stakeholders have been interviewed for the collation of this report. It provides an in-depth evaluation of the market for stem cell therapies and also aids in gaining insights into the prime strategies adopted by the key players operating in the market. It also encapsulates key dynamics such as the challenges, trends, drivers, and opportunities impacting the development of this market.
The report starts by presenting an overview of the stem cell therapies market. This section comprises the definition of stem cell therapies, types of stem cells, and a timeline of the prime events that have taken place in research into stem cells. Stem cells are the most vital type of cells found in animals, including human beings. They are the precursors of all cells present in the human body and possess the ability to replicate themselves and replace or repair any other damaged tissues within the human body.
Stem cell therapies involve the utilization of stem cells in the prevention or treatment of various conditions or chronic diseases, including cancer and blood disorders. Currently, bone marrow transplants are the most commonly utilized stem cell therapy globally.
Click here to get more info with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=760965
As stated in the report, stem cell therapies also offer an extremely lucrative platform for clinical developments in areas where surgical treatment and pharmacological options aren’t effective. As per the report, currently, the prime marketed stem cell therapy products are Cellgram-AMI (Pharmicell), Prochymal (Mesoblast), CardioRel (Reliance Life Sciences), Cartistem (Medipost), Trinity Elite (Orthofix International), Holoclar (Chiesi Farmaceutici), and Osteocel Plus (NuVasive).
The prime factors impacting the growth of the stem cell therapies market have been elaborated upon under the next section of this study. The consistent development in clinical research and the growing product efficiency will fuel the growth of the market. In addition, the rising regulatory support and the increasing funding by governments will also augment the growth of the market for stem cell therapies.
On the other hand, the lack of advanced infrastructure for research into stem cell therapies and the increasing ethical problems involved in the utilization of embryonic stem cells are amongst the prime factors impeding the growth of the stem cell therapies market, as per this study.
In the following section of the report, the pipeline of stem cell therapies has been presented. The stem cell therapy pipeline has been evaluated on the basis of stage of development and therapy area. Furthermore, the top companies operating in the market for stem cell therapies have also been presented in the report.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org